2nd SOHO Italian Conference

http://www.sohoitaly.it/

 

Lymphoma
15:16

2nd SOHO Italian Conference

Updates on HL: Pembro Mono in Untreated Patients, Brentuximab Vedotin + Nivo Combo in Older Population, the Use of Anti-CD30 CAR-T in R/R Disease

FEATURING Antonello Pinto
  • 119 views
  • January 27, 2021
  • 1
10:28

2nd SOHO Italian Conference

Genomics & DLBCL: How Do Alterations of Ribosomal Protein Genes Occur? Are They Mutually Exclusive With TP53 Mutations?

FEATURING Enrico Derenzini
  • 14 views
  • January 27, 2021
11:13

2nd SOHO Italian Conference

Updates on Waldenstrom Macroglobulinemia: Does Ibrutinib Improve OS/PFS in Treatment-Naïve Disease? Is Rituximab the Best Maintenance Option? Can We Achieve CR With Zanubrutinib?

FEATURING Alessandra Tedeschi
  • 31 views
  • January 27, 2021
15:14

2nd SOHO Italian Conference

How I Treat Lymphomas: Is 1L Obi+Chemo Beneficial for PFS in FL? RIT vs. ASCT - What to Choose in R/R FL? Is Ibrutinib the Best Choice for R/R MZL? Can Older MCL Patients Benefit From R-BAC Induction?

FEATURING Stefano Luminari
  • 173 views
  • January 27, 2021
  • 1
12:29

2nd SOHO Italian Conference

Managing Hodgkin Lymphoma: PET Adapted Strategies, Applying ECHELON-1 Trial Data to the Frontline Setting

FEATURING John Leonard
  • 230 views
  • December 8, 2020
  • 2
19:44

2nd SOHO Italian Conference

How I Treat DLBCL in 2020: Who Shouldn't Get Standard Treatment? Is Intensity Less Important Over Age 80? Can We Do Better Than R-CHOP? Why Do Targeted Strategies Fail?

FEATURING
  • 476 views
  • December 7, 2020
  • 4